G210315-NCT05406622

Dynamic List Information
Dynamic List Data
Study Title
A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared With Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions
Sponsor Name
REVA Medical, Inc.
NCT Number
NCT05406622
IDE Number
G210315
CMS Approval Date
2022-12-08
Category
A